Background: Infection diagnosis can be challenging, relying on clinical judgement and non-specific markers of infection. We evaluated a supervised machine learning (SML) algorithm for diagnosing bacterial infection using routinely available blood parameters on presentation to hospital.
Introduction
The diagnosis and empirical management of infection in hospital can be challenging, particularly on admission. Diagnosis of infection generally relies on clinical acumen, physiological parameters and non-specific markers of inflammation, such as C-reactive protein (CRP). 1, 2 Recently, there has been a focus on the early recognition and management of sepsis, which forms the severe end of the infection spectrum that presents in hospital. 3, 4 For the recognition of sepsis there is now a wide range of clinical decision tools, including the National Early Warning Score 2 (NEWS 2) in the UK [5] [6] [7] [8] [9] [10] [11] [12] [13] and electronic decision support, such as sepsis alert systems. 8, 14, 15 These tools aim to support the early detection and management of sepsis, which has been shown to reduce mortality in this condition. 16, 17 These decision support tools focus on the recognition of deterioration in physiological parameters, such as blood pressure and respiratory rate. 18 The implementation of the NEWS 2 score in the emergency department has demonstrated good sensitivity for recognition of critically ill patients with sepsis. 5, 18, 19 Outside of sepsis, there is little support for clinicians to make decisions about infection diagnosis and management. For example, the diagnosis of urinary tract infections and respiratory tract infections can be more nuanced. [20] [21] [22] Often the clinician does not have specific evidence of infection, such as temperature or radiological evidence, and is therefore forced to make a decision based on reported symptoms, non-specific clinical signs and altered inflammatory markers. 1, 2 Antimicrobial therapy is often commenced in advance of microbiological confirmation, exposing the patient to potentially inappropriate or unnecessary treatment.
With advances in computer processing and artificial intelligence, attempts have been made to develop intelligent tools that can learn and automate decision support without the need for human input, including the diagnosis of infection. 23, 24 However, concerns have been raised about the unsupervised nature of such systems, which may allow errors in the system to go unnoticed or even propagate. 25 This is because an unsupervised system by definition learns in an unguided fashion, being trained using data that is not associated with any pre-defined outcome label (e.g. infection versus no infection). Given this argument, there is a need to explore methods of developing supervised systems that can learn in a controlled way and be utilized by the physician to support them in making well-informed, patient-centred decisions. 25 Given the diagnostic challenges associated with these types of infective presentation and the need to optimize antimicrobial prescribing, we investigated the development of a supervised machine learning algorithm, embedded within a clinical decision support system for the diagnosis of infection on presentation to hospital. 26, 27 This study aimed to use routine blood test data to support clinicians in diagnosing infection occurring within 72 h of presentation to hospital.
Methods

Study setting
This study took place at Imperial College Healthcare NHS Trust (ICHNT), comprising three university teaching hospitals. The hospital network shares an electronic health record system, infection management policies and staff who work across sites. The study took place between October 2017 and March 2018. Two researchers (T. M. R. and B. H.) were responsible for collection and primary analysis of data. The study was reported following the STROBE criteria for observational cohort studies. 28 
Clinical decision support system
A clinical decision support system (CDSS), called Enhanced Personalized Integrated Care for Infection Management at the Point Of Care (EPIC IMPOC), was incorporated into the ICHNT electronic health record system. This CDSS contained machine learning modules designed to support antimicrobial selection, dose optimization tools and a patient engagement module. All of the designed modules utilized routinely available data to provide individualized infection management recommendations to healthcare professionals.
Supervised machine learning algorithm
The development and cross-validation of supervised machine learning algorithms for the inference of infection using routinely available microbiology and blood test data have been previously described in detail. 26 Briefly, a Support Vector Machine (SVM) binary classifier algorithm was developed and incorporated into the EPIC IMPOC CDSS for investigation within this study following validation and pilot assessment. SVM classifiers are one of the newest techniques within the field of supervised machine learning. [29] [30] [31] SVMs work by taking data with categories already assigned to it (e.g. infection versus no infection) and then maximize the distance, or 'margin', that sits either side of a linear divide that separates the two classes of data ( Figure 1) . [29] [30] [31] By maximizing the distance between the two data classes, SVM aims to reduce the expected error in estimations made by the algorithm. Once the optimal way of separating the data classes is found (Figure 1 ), the data points that lie on the edge of the divide, known as the support vector points, are selected and all other data is discarded. These support vector points are then used for classification purposes when new data are introduced to the algorithm. [29] [30] [31] Although the improved accuracy of SVM is desirable, there are also limitations. Firstly, it is not always possible to identify a linear divide between two classifications. This often requires use of a transformed feature space, where a Kernel function is added to the algorithm to facilitate classification. [29] [30] [31] To develop the SVM algorithm, a range of relevant, electronically collected data was identified and extracted to create a training dataset. This included clinical bacterial microbiology data, which were extracted from the central microbiology records for all clinical samples received by the North West London Pathology laboratory from 2009 to 2015. Blood test parameters were also extracted for all patients within the Trust during this time period. To select variables for linkage to microbiology records a threestep approach was taken. Firstly, variables reported by physicians as being important during infection management were identified.
1 Secondly, two infection specialists were asked to review these variables and corroborate the findings. Finally, relevant literature was reviewed to provide further evidence in support of these selected variables.
Six variables were eventually selected based on their availability electronically and their use in infection management. These variables were CRP, white cell count (WCC), creatinine (Cr), ALT, bilirubin (BIL) and alkaline phosphatase (ALP). [32] [33] [34] [35] [36] [37] [38] Lactate was also felt to be an important blood marker for inclusion; however, at the time of development this was not routinely available for the majority of patients within the electronic database. [39] [40] [41] Furthermore, physiological parameters (heart rate, respiratory rate, temperature, blood pressure and oxygen saturation) were not available electronically. 4, [42] [43] [44] Following selection of the variables, individual Machine learning for infection diagnosis JAC patient profiles were linked to bacterial microbiology data. Linkage was performed in the following way. Initially all individual patient blood test profiles (n " 1251830) were labelled as 'no culture'. For individuals who had positive and confirmed bacterial microbiology results (n 350000) within 48 h of a blood test result, these were then labelled as 'positive culture'. If further blood test results for 'positive culture' individuals were available before or after the 48 h window, but in the same admission, these were excluded. This yielded two groups of patient profiles that were labelled either 'no bacterial culture' or 'positive bacterial culture'. Curation of the dataset was then performed prior to further processing to remove corrupt data. Corrupt data can be defined as erroneous, imprecise or missing data. [45] [46] [47] It has been demonstrated to be important to address these issues within machine learning to ensure that predictions by the system remain robust. 48 This stage focused on:
1. Removal of outliers: This has been demonstrated to significantly increase the robustness of machine learning tools. 48 In this study, outliers are likely to be due to human error in data input or erroneous results secondary to technical factors such as diagnostic accuracy or contamination. We defined outliers using the IQR rule, which takes any variables outside of 1.5 % IQR to be an outlier, and removed them from the dataset. 48 2. Missing data: Within this study we evaluated the impact of missing blood parameters on the accuracy of the tool during cross-validation as outlined below. Of the six variables, the system provided stable results providing that 4 variables were present. 26 For training, however, patient profiles were required to contain all six variables. 3. Class imbalance: Invariably, there was likely to be a class imbalance in numbers of individuals between those with 'no culture' and 'positive culture'. To address this, an approach called Synthetic Minority Over-Sampling Technique was used. 48 This approach combines undersampling of the majority classifier and oversampling of the minority classifier group and has been demonstrated to enhance the performance of data that use this. 48 Following data curation, 160203 individual patient profiles containing all six blood variables were available to train and test the diagnostic ability of the SVM algorithm using a standard 10-fold cross-validation approach. 26 For the purpose of this study, the inference of likely positive bacterial microbiology was taken as a proxy for inferring the likelihood of a bacterial infection diagnosis in an individual patient.
Participant inclusion and follow-up
To ensure sample size was adequate to power our analysis (see Statistical analysis section) four periods of data collection were undertaken between October 2017 and March 2018. One researcher (T. M. R.) identified the first 20-30 adult patients admitted to ICHNT on the selected day using the hospital electronic health record system for inclusion in the study. Paediatric and psychiatric admissions and maternity patients were not included. Data collection was planned to continue in cycles of recruitment until 100 or more patients had been identified. Individuals' blood parameters on admission to hospital were automatically extracted by the CDSS and inputted into the supervised machine learning algorithm. This provided an automated likelihood estimate for the diagnosis of bacterial infection. Individuals were then prospectively followed up by two researchers (T. M. R. and B. H.) until discharge to determine those who went on to be diagnosed with a community-acquired bacterial infection within this first 72 h of admission. The time frame of 72 h was selected as this represents our local definition for community-acquired infection given that the SVM was developed to predict infection based on blood results from admission to hospital. Routine electronic data for individuals were anonymously extracted for analysis including demographic, laboratory, clinical, treatment and outcome parameters.
The presence of infection was assessed using a pre-determined clinical case definition. Assessment was performed independently by two researchers (T. M. R. and B. H.). The criteria defining infection were the presence of a clinically relevant microbiological culture with one or more categories in keeping with a bacterial infection (i.e. the presence of raised temperature, change in physiological parameters, raised inflammatory markers, radiological evidence or infective signs or symptoms). If microbiological culture results were not available then two or more categories were required for confirmation. Where antimicrobial therapy was prescribed, but these criteria were not present or disagreement occurred, the researcher's opinion was triangulated by an independent infection specialist and the local antimicrobial policy reviewed to compare the treating clinician's action against current guidelines within the hospital. This study was an observational evaluation of the ability of the system to predict infection in patients presenting to hospital only. The treating physicians were blinded to the use of the system to avoid influencing the diagnosis of infection, the request of blood tests and management decisions made.
Statistical analysis
Analysis was performed using SPSS 24.0 (IBM, Chicago, IL, USA). Figures were plotted using R (R core team 2013) and IGOR Pro 7.0 (WaveMetrics, OR, USA). Performance of the SVM classifier algorithm was assessed using receiver operating characteristics (ROC) AUC analysis. An ROC AUC was used to assess the sensitivity and specificity of the supervised machine learning tool, with an optimal cut-off value explored to maximize the system's sensitivity and specificity. 49, 50 To estimate the required sample size, a power calculation was performed. This calculation used the methodology proposed by Bujang and Adnan for estimating a minimum sample size when performing sensitivity and specificity analysis. 51 For this study, we set the power at 80% and significance value at ,0.05. Based on pilot work, we set our null hypothesis value as 0.70 for both sensitivity and specificity with an alternative hypothesis of 0.90 for both, respectively. The prevalence of patients within our cohort likely to be admitted with infections/started on antibiotics during the admission process was estimated at approximately 50%-60% based on point-prevalence work within ICHNT. Using the estimates made by Bujang and Adnan, we aimed to include at least 62 individuals, 31 of whom went on to develop infections to ensure that the study was appropriately powered. 51 For statistical analysis of descriptive data t-tests, Mann-Whitney U and v 2 tests were used on parametric and non-parametric data, where appropriate.
Ethics
Ethics approval for this study was granted by London-Chelsea Regional Ethics Committee (REC: 17/LO/0047) and local service evaluation procedures were followed (registered SE113). All CDSS features were developed in line with the current directives of the Data Protection Act 1998, the Privacy and Electronic Communications Directive 2003 and the EU Directive 2006/24/EC for data retention. 52, 53 Internally, approval for the system to transfer and anonymize patient-identifiable data (Caldicott approval) was granted by ICHNT Information Governance (Ref. 23307/726505). Antibiotics were prescribed to 37/104 (36%) individuals, with 31/37 (84%) being intravenous therapy. Two individuals died during the hospital stay and after 72 h in hospital. One of these was related to infection, the other to an underlying malignancy. Table 1 cases. Two of these were urine samples from female patients with no symptoms, one was an MRSA screening swab in a patient who was undergoing suppressive treatment and one was a skin swab that grew Gram-positive cocci and was not further cultured as it was felt to be clinically insignificant. Those with bacterial infection received antimicrobial therapy in 33/36 (92%) cases, 28/33 (85%) being intravenous therapy. Of those without evidence of bacterial infection, 4/68 (6%) were prescribed antimicrobials with 3/4 (75%) receiving intravenous antimicrobials.
Results
Summary of the cohort
Supervised machine learning for the prediction of infection
On input of patient blood parameters during admission to hospital the supervised machine learning algorithm provided probabilities of infection for each individual included within the study. Of those who went on to develop an infection, the mean (SD) likelihood estimate was 0.80 (0.09) compared with 0.50 (0.29) in those without infection. Figure 2 demonstrates the ROC of the supervised machine learning algorithm for the diagnosis of infection within 72 h of admission to hospital. The ROC AUC was 0.84 (95% CI: 0.76-0.91). Analysis of cut-off values for the ROC analysis demonstrated that setting a cutoff estimate at 0.81 would demonstrate a sensitivity of 89% and a specificity of 63%. A likelihood estimate cut-off at 0.82 demonstrated a sensitivity of 44% and a specificity of 93%. Using both cut-off values, the three patients with bacterial infection but not prescribed antibiotics were classified as infected. For patients prescribed antibiotics but not meeting the clinical case definition for infection, a cut-off of 0.812 meant that one of the four patients was classified as not infected. Using a cut-off of 0.820, three out of the four of these individuals were classified as not infected.
Discussion
Within our study, a supervised machine learning algorithm, embedded within a clinical decision support system was able to identify bacterial infection using a small number of blood parameters that are routinely available on admission to hospital. The type of decision support provided by this system may offer a number of potential benefits over the traditional decision support mechanisms that surround the investigation, diagnosis and management of infection.
This study highlights the challenge of diagnostic uncertainty in determining infection. In this study, physicians performed well at diagnosing bacterial infection (92% sensitivity, 94% specificity) in a cohort of general patients admitted to hospital. However, there were a small proportion of individuals who were not identified by physicians as having a bacterial infection upon admission to hospital (3/36; 8%). These individuals therefore did not receive appropriate investigation for, or treatment of, infection. Similarly, there were a small number of individuals who did not have evidence of bacterial infection but received antimicrobial therapy regardless (4/68; 6%). Although only a small proportion of the total, when contextualized for all admissions to our hospital Trust over a 1 year period (50000 patients), this is likely to equate to a large number of patients either being undertreated or exposed to unnecessary antimicrobial therapy.
Furthermore, when considering those with bacterial infection, the process of microbiological sampling was often neglected in advance of starting antimicrobial therapy. Of the 36 individuals with bacterial infection, 3 (8%) had no microbiological sampling performed of any kind prior to or after commencement of antibiotic treatment. Only 19 (53%) patients with bacterial infection yielded a positive culture. This means that targeted antimicrobial therapy often cannot be prescribed, given the paucity of microbiological confirmation. This has the potential to impact the practice of prescribing, meaning that empirical therapy is often continued using broad-spectrum antimicrobial agents, owing to diagnostic uncertainty. 54 With the implementation of systems such as supervised machine learning algorithms, decision support may be provided to healthcare providers indicating those individuals with a high likelihood of infection, potentially driving enhanced microbiological sampling prior to clinical review/initiation of antimicrobial therapy. This would include supporting decision-making in more challenging situations, such as those individuals not treated for bacterial infection on admission in this study.
Finally, with a growing focus on the development of decision support mechanisms for antimicrobial management in resourcelimited settings, the role of an algorithm that can work with limited numbers of variables may be attractive across a range of healthcare settings. Within this study, only a single sample of four to six blood parameters proved adequate for the system to predict the likelihood of infection.
With the development of more advanced supervised machine learning tools, these classifier systems may also demonstrate the ability to provide a broader scope of decision support for antimicrobial prescribing. Similar classifier systems have already been explored for the prediction of causative organism and serotype of viral infections. For example, TREAT, a decision support system containing causal probabilistic networks has previously explored the ability to predict the likelihood of bloodstream infection and the causative organism. 23, 24 Other examples include the use of Machine learning for infection diagnosis JAC Decision Tree Classifiers using binary classification applied to blood test parameters to predict the diagnosis of Chlamydia pneumoniae 32 and hepatitis B/C virus. 33 These approaches have yielded mixed results, demonstrating an overall potential for supporting decision-making using these techniques. However, with the development of more advanced techniques, such as SVM, and the availability of population-level datasets this may provide the ability to expand classifiers to other aspects of decision-making, including selection of the optimal length of treatment and intravenous versus oral delivery. Moreover, with concerns over the role of unsupervised machine learning tools and the need for artificial intelligence to be developed to provide better evidence in support of clinicianled, patient-centred decision-making, this approach could potentially provide better evidence in support of infection management than is currently available for clinicians assessing the patient on presentation to hospital.
This study has several limitations that must be considered. Firstly, although powered to demonstrate significance during sensitivity and specificity analysis, a relatively small cohort of patients was included in this study. Furthermore, the external validity is unclear given that our algorithm was developed and tested on data from three geographically similar hospitals in West London. Secondly, this study was observational only, meaning that the impact of the algorithm on clinician decision-making was not assessed. Thirdly, although several other variables were identified as desirable during the development of the algorithm (such as lactate and physiological parameters) these variables were not electronically available for all individuals during development of the algorithm. This is subsequently being addressed as part of the future direction of this project. Fourth, the identification and diagnosis of true bacterial infection in the absence of microbiological evidence can be challenging. Although a systematic approach was taken to determine infection in this study, the clinical case definitions used may have influenced our findings. Finally, direct comparison with current clinical decision support tools is not practical, given that they focus primarily on the detection of sepsis only. Other positive cultures: wound swab %3 (Serratia marcescens; MRSA and b-haemolytic streptococcus; and Staphylococcus aureus), joint fluid (S. aureus), biliary drain fluid (E. coli) and pleural fluid (S. aureus). c n " 37.
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Future work will now explore the integration of this system with other forms of decision support housed within EPIC IMPOC and evaluate the direct impact of the algorithm on infection management in secondary care.
Conclusions
A supervised machine learning algorithm embedded within a clinical decision support tool can support the diagnosis of infection in patients presenting to hospital. Future work must explore the potential impact of classifier systems similar to this on the decisionmaking of clinicians who manage infections as part of multimodal decision support packages. Cut-off values: Likelihood 0.812; sensitivity = 89%, specificity = 63% Likelihood 0.820; sensitivity = 44%, specificity = 93% Figure 2 . ROC curve for the prediction of infection using a supervised machine learning algorithm and routine blood parameters on admission to hospital.
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